TY - JOUR
T1 - Clinical care of pregnant and postpartum women with COVID-19
T2 - Living recommendations from the National COVID-19 Clinical Evidence Taskforce
AU - Vogel, Joshua P.
AU - Tendal, Britta
AU - Giles, Michelle
AU - Whitehead, Clare
AU - Burton, Wendy
AU - Chakraborty, Samantha
AU - Cheyne, Saskia
AU - Downton, Teena
AU - Fraile Navarro, David
AU - Gleeson, Glenda
AU - Gordon, Adrienne
AU - Hunt, Jenny
AU - Kitschke, Jackie
AU - McDonald, Steven
AU - McDonnell, Nolan
AU - Middleton, Philippa
AU - Millard, Tanya
AU - Murano, Melissa
AU - Oats, Jeremy
AU - Tate, Rhiannon
AU - White, Heath
AU - Elliott, Julian
AU - Roach, Vijay
AU - Homer, Caroline S.E.
AU - on behalf of the National COVID-19 Clinical Evidence Taskforce
PY - 2020/12
Y1 - 2020/12
N2 - To date, 18 living recommendations for the clinical care of pregnant and postpartum women with COVID-19 have been issued by the National COVID-19 Clinical Evidence Taskforce. This includes recommendations on mode of birth, delayed umbilical cord clamping, skin-to-skin contact, breastfeeding, rooming-in, antenatal corticosteroids, angiotensin-converting enzyme inhibitors, disease-modifying treatments (including dexamethasone, remdesivir and hydroxychloroquine), venous thromboembolism prophylaxis and advanced respiratory support interventions (prone positioning and extracorporeal membrane oxygenation). Through continuous evidence surveillance, these living recommendations are updated in near real-time to ensure clinicians in Australia have reliable, evidence-based guidelines for clinical decision-making. Please visit https://covid19evidence.net.au/ for the latest recommendation updates.
AB - To date, 18 living recommendations for the clinical care of pregnant and postpartum women with COVID-19 have been issued by the National COVID-19 Clinical Evidence Taskforce. This includes recommendations on mode of birth, delayed umbilical cord clamping, skin-to-skin contact, breastfeeding, rooming-in, antenatal corticosteroids, angiotensin-converting enzyme inhibitors, disease-modifying treatments (including dexamethasone, remdesivir and hydroxychloroquine), venous thromboembolism prophylaxis and advanced respiratory support interventions (prone positioning and extracorporeal membrane oxygenation). Through continuous evidence surveillance, these living recommendations are updated in near real-time to ensure clinicians in Australia have reliable, evidence-based guidelines for clinical decision-making. Please visit https://covid19evidence.net.au/ for the latest recommendation updates.
KW - Australia
KW - COVID-19
KW - guidelines
KW - perinatal care
KW - pregnancy
UR - https://www.scopus.com/pages/publications/85094666923
U2 - 10.1111/ajo.13270
DO - 10.1111/ajo.13270
M3 - Article
C2 - 33119139
AN - SCOPUS:85094666923
SN - 1479-828X
VL - 60
SP - 840
EP - 851
JO - Australian and New Zealand Journal of Obstetrics and Gynaecology
JF - Australian and New Zealand Journal of Obstetrics and Gynaecology
IS - 6
ER -